Finally, R94Q MFN2 appears to lead to reduction in MERCS both in CMT2A patient-derived fibroblasts and primary neurons in vitro and in vivo in motoneurons of the above-mentioned mouse model of CMT2A [17]. Here, MFN2 is linked to Charcot-Marie-Tooth disease type 2A1.